肝细胞癌的表观遗传疗法:新兴的临床工具和应用
Barbara Bueloni1,2,3, Maite G Fernandez-Barrena4,5, Esteban Fiore1,2
1Hepatology and Gene Therapy Program, Instituto de Investigaciones en Medicina Traslacional, CONICET - Universidad Austral, Pilar, Buenos Aires, Argentina.
Gut
|September 23, 2025
概括
表观遗传失调驱动肝细胞癌 (HCC) 的进展和治疗耐药性. 针对这些表观遗传机制提供了一个有希望的新策略,以提高HCC治疗效率和患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 肝细胞癌研究 肝细胞癌研究
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因,晚期治疗疗效有限.
- 肝癌的发展与慢性肝病和肝硬化有关,包括炎症和遗传/表观遗传变化.
- 在HCC中瘤异质性有助于抵抗目前的治疗方法,如氨酸激酶抑制剂和免疫检查点抑制剂.
研究的目的:
- 提供对HCC的表观遗传疗法的全面概述.
- 总结临床试验结果,用于治疗HCC的epidrugs.
- 探索如何向表观遗传机制可以克服治疗阻力.
主要方法:
- 已完成和正在进行的临床试验的审查,涉及HCC.
- 对表观遗传失调在HCC进展和治疗耐药性的作用的分析.
- 对针对HCC的表观遗传机制进行当前研究的综合.
主要成果:
- 表观遗传失调被确定为HCC瘤进展的关键驱动因素.
- 流行药物显示出抑制瘤生长和逆转抗药途径的潜力.
- 针对表观遗传学可能会提高现有的HCC疗法的有效性.
结论:
- 表观遗传疗法代表了HCC干预的新前沿.
- 向表观遗传机制可能会改善HCC的治疗反应和耐久性.
- 表观遗传学有望重塑HCC管理,以实现更个性化的策略.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
6.0K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.8K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K